Concerning lung cancer, SLC2A1 was observed highly expressed in patients of Lung adenocarcinoma (LUAD) which its development could be inhibited by SLC2A1 through various molecular pathways13. This evidence concerns the gene SLC2A1 and lung carcinoma.